Sulindac | m-entrepreneurship.com

Product Name :
Sulindac

Search keywords :
Sulindac

drugId :
null

Target Vo:
Cyclooxygenases

Target Vo Short Name :
COXs

Moa_Name:
Cyclooxygenases inhibitors

First Approval Country :
United States

First Approval Date Filter:
1978

Origin Company_Name :
Merck & Co Inc

Active Company_Name :
Medical University Of South Carolina

Active Indication_Name:
Osteoarthritis

In Active Indication_Name:
Precancerous Conditions

Termination Status :

China Termination Status :

Highest Status:
Approved

China Highest Status:
Approved

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
RIP Rabbit mAb Description
NR1D1 Antibody (YA1426) custom synthesis
Phospho-Acetyl Coenzyme A Carboxylase (Ser79) Antibody: Phospho-Acetyl Coenzyme A Carboxylase (Ser79) Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 266 kDa, targeting to Phospho-Acetyl Coenzyme A Carboxylase (Ser79). It can be used for WB assays with tag free, in the background of Human.

Author: Betaine hydrochloride

Related Posts